Paraplatin

Active Ingredient(s): Carboplatin
FDA Approved: * March 3, 1989
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Plazomicin Overview

Plazomicin, sold under the brand name Zemdri, is an aminoglycoside antibiotic used to treat complicated urinary tract infections.[1] As of 2019 it is recommended only for those in whom alternatives are not an option.[1] It is given by injection into a vein.[1] Common side effects include kidney problems, diarrhea, nausea, and blood pressure changes.[1] Other severe side effects include hearing loss, Clostridium difficile-associat...

Read more Plazomicin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Plazomicin

Recent Plazomicin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Plazomicin
  • Injection: 50mg/ml
  • Solution: 500mg/10ml (50mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Plazomicin: (2 results)

Sorted by National Drug Code
  • 69097-820 Zemdri (Plazomicin) 500 mg/10ml Intravenous Injection by Cipla USA Inc.
  • 71045-010 Zemdri (Plazomicin) 500 mg/10ml Intravenous Injection by Achaogen, Inc.

Other drugs which contain Plazomicin or a similar ingredient: (1 result)